Mingfeng Capital
Overview
Mingfeng Capital is a China-based private equity investment firm focused on the healthcare and medical sectors, with a particular emphasis on consumer medical and aesthetic medicine.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Jiangsu Trausim Medical Instrument Co., Ltd. | Nov 2022 | Series A | Lead |
| Worg Pharmaceuticals | Dec 2025 | Series D Extension | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Mingfeng Capital based?
Mingfeng Capital is headquartered in Beijing, China.
When was Mingfeng Capital founded?
Mingfeng Capital was founded in 2015.
How many portfolio companies does Mingfeng Capital have?
Mingfeng Capital has 2 portfolio companies in Caplight's dataset.
What are some companies in Mingfeng Capital's portfolio?
Portfolio companies visible on Caplight include Jiangsu Trausim Medical Instrument Co., Ltd., Worg Pharmaceuticals.
What was Mingfeng Capital's most recent investment shown here?
Mingfeng Capital's most recent investment in this portfolio sample was in Worg Pharmaceuticals in 2025.
What sectors does Mingfeng Capital focus on?
Mingfeng Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech.
What company stages does Mingfeng Capital focus on?
Mingfeng Capital typically invests at the Early stage.